James Ward-Lilley
Vorsitzender bei Adherium (NZ) Ltd.
Vermögen: 3 429 $ am 30.04.2024
Profil
James Ward-Lilley is currently the Independent Non-Executive Chairman at Adherium (NZ) Ltd.
and a Director at Vectura Group Investments Ltd., Aerogen Pharma Ltd., Aerogen Ltd., and Galway Group LLC.
Previously, he served as the Chief Executive Officer & Executive Director at Vectura Group Ltd.
from 2015 to 2019, and as the Chief Executive Officer & Director at Vectura GmbH.
He was also a Director at Vectura Ltd.
and Vectura Group Services Ltd.
Additionally, he worked as the Head-Investor Relations at AstraZeneca PLC from 2011 to 2012.
He briefly served as the Independent Non-Executive Chairman at Adherium Ltd.
from 2020 to 2022.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADHERIUM LTD.
0,07% | 30.11.2022 | 239 969 ( 0,07% ) | 3 429 $ | 30.04.2024 |
Aktive Positionen von James Ward-Lilley
| Unternehmen | Position | Beginn |
|---|---|---|
Vectura Group Investments Ltd.
 Vectura Group Investments Ltd. Medical SpecialtiesHealth Technology Founded in 2010, Vectura Group Investments Ltd. is a subsidiary of Philip Morris International, Inc. that manufactures products for airways diseases. The company is based in Chippenham, UK. | Direktor/Vorstandsmitglied | 31.07.2018 |
| Galway Group LLC | Corporate Officer/Principal | - |
Aerogen Ltd.
 Aerogen Ltd. Medical SpecialtiesHealth Technology Aerogen Ltd. develops and manufactures aerosol products. It offers Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-X controller and USB controller. The company was founded by John S. Power in 1997 and is headquartered in Galway, Ireland. | Corporate Officer/Principal | - |
| Aerogen Pharma Ltd. | Direktor/Vorstandsmitglied | - |
Adherium (NZ) Ltd.
 Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand. | Vorsitzender | 14.04.2020 |
Ehemalige bekannte Positionen von James Ward-Lilley
| Unternehmen | Position | Ende |
|---|---|---|
| ADHERIUM LIMITED | Vorsitzender | - |
| VECTURA GROUP | Vorstandsvorsitzender | 30.06.2019 |
Vectura Group Services Ltd.
 Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Vectura Group Services Ltd. provides business support services. The company is based in London, UK. | Direktor/Vorstandsmitglied | 30.06.2019 |
| ASTRAZENECA PLC | Investor Relations Kontakt | 01.01.2012 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| ADHERIUM LIMITED | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Aerogen Ltd.
Aerogen Ltd. Medical SpecialtiesHealth Technology Aerogen Ltd. develops and manufactures aerosol products. It offers Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-X controller and USB controller. The company was founded by John S. Power in 1997 and is headquartered in Galway, Ireland. | Health Technology |
Adherium (NZ) Ltd.
Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand. | Technology Services |
Vectura Ltd.
 Vectura Ltd. Medical SpecialtiesHealth Technology Part of Philip Morris International, Inc., Vectura Ltd. is a leading inhalation CDMO that provides innovative inhaled drug development solutions to help bring medicines to market. The company is based in Chippenham, UK, and has planning permission for a new 10,000-square meter facility on Bristol & Bath Science Park - inhalation center of excellence. Vectura is reimagining healthcare and self-care, transforming the lives of airways disease patients. Founded in 1983, the British company specializes in formulation science, device technology, and inhaled development expertise to bring DPI, PMDI, and nebulizer medicines to market. | Health Technology |
Vectura Group Services Ltd.
Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Vectura Group Services Ltd. provides business support services. The company is based in London, UK. | Commercial Services |
Vectura Group Investments Ltd.
Vectura Group Investments Ltd. Medical SpecialtiesHealth Technology Founded in 2010, Vectura Group Investments Ltd. is a subsidiary of Philip Morris International, Inc. that manufactures products for airways diseases. The company is based in Chippenham, UK. | Health Technology |
| Galway Group LLC | |
| Aerogen Pharma Ltd. | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
